中文 | English
Return
Total: 22 , 1/3
Show Home Prev Next End page: GO
Author:( Yongfang HU)

1.Cost-effectiveness Analysis of Three Therapeutic Schemes for Sudden Deafness

Yongfang HU ; Zhongqi LIU

China Pharmacy 2001;12(4):221-222

2.Influence of multiple gene variation on IVF outcome

Yao YAO ; Yongfang HU

Chinese Pharmacological Bulletin 2010;26(1):14-17

3.Pharmaceutical Care for Hypertensive Patients after Renal Transplantation

Yongfang HU ; Suodi ZHAI

China Pharmacy 2007;0(32):-

4.Contribution of genetic polymorphisms of the CYP3A4, CYP3A5 and MDR1 genes to cyclosporine disposition

Yongfang HU ; Honghao ZHOU

Chinese Pharmacological Bulletin 1987;0(03):-

5.ZMS regulation of M_2 muscarinic receptor stability mediated by de novo synthesis of protein

Yongfang ZHANG ; Zongqin XIA ; Yaer HU

Journal of Shanghai Jiaotong University(Medical Science) 2009;29(11):1324-1327

6.Pharmacognostical identification of Schizocapsa plantaginea

Fei PENG ; Yongfang HU ; Jiancun LIU ;

Chinese Traditional and Herbal Drugs 1994;0(08):-

7.Pharmaceutical Care for Inpatients with Bronchial Asthma

Sitan GULI ; Yongfang HU ; Suodi ZHAI

China Pharmacy 1991;0(05):-

8.Correlation between MDR1 genetic polymorphism and prognosis in acute leukemia

Dan WANG ; Xiaoyan KE ; Yongfang HU

Chinese Pharmacological Bulletin 1986;0(06):-

9.Effect of CYP3A5~*3 and CYP3A4~*18B genetic polymorphisms on cyclosporine pharmacokinetics in renal transplant patients

Yongfang HU ; Suodi ZHAI ; Wen QIU

Chinese Pharmacological Bulletin 1987;0(03):-

10.A Study on 44 Cases of Clavicular Fracture

Lihuang YAN ; Yongfang HU ; Shanmi WANG

Chinese Journal of Perinatal Medicine 1998;0(03):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 22 , 1/3 Show Home Prev Next End page: GO